Covance Not Cooling...
Health Care: Drugs
Ardea Biosciences Inc. (RDEA: NASDAQ)
$31.96 -0.02 | -0.06%
06/19/12 - 04:00 PM ET
TheStreet Ratings Grade for RDEA
| Buy | Hold | Sell | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A+ | A | A- | B+ | B | B- | C+ | C | C- | D+ | D | D- | E+ | E | E- | F |
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions.
Analyst Ratings
| Historical Rec | Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago |
|---|---|---|---|---|
| Strong Buy | 4 | 4 | 12 | 10 |
| Moderate Buy | 0 | 0 | 0 | 0 |
| Hold | 8 | 8 | 2 | 2 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 2.33 | 2.33 | 1.29 | 1.33 |
Portfolios with RDEA
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 19
- ContributorHot Biotech Stocks Traded b...
- UserGFNN Stockdiagnostics 14
- Contributor10 Stocks That Fidelity Fun...
- ContributorStocks With Big Insider Buy...
- Contributor10 Small-Cap Stocks With No...
- ProDuquesne Capital
- ContributorBarron's Activist Stocks 4-...
- ContributorBarron's Insider Purchases ...
- UserNymph's Russell 2000 Rebala...
Latest RDEA Headlines from TheStreet
- AstraZeneca Buys Ardea Biosciences for $1.26 Billion: Hot Trends
04.23.12 | 10:04 am - AstraZeneca Buys Ardea Biosciences for $1.26B: Hot Trends 04.23.12 | 08:04 am
- 10 Stocks That Fidelity Funds Are Buying 04.11.12 | 06:04 am
- 5 Stocks Insiders Love Right Now 02.09.12 | 10:02 am
- Insiders Trading WEN, UA, LULU, RDEA 02.06.12 | 08:02 am
- Ardea Stock Falls On Unusually High Volume (RDEA) 02.01.12 | 10:02 am
- Biocryst's Gout Drug Fails to Impress 10.05.11 | 11:10 am
- Ardea Stock Hits New 52-Week Low (RDEA) 08.08.11 | 10:08 am
- Insiders Trading RDEA, JPM, AMTD, RLOG 01.25.11 | 10:01 am
- 10 Small-Cap Stocks With No 'Sell' Ratings 10.04.10 | 06:10 am
Press Releases for RDEA
- Securities Lawyers At Goldfarb LLP Seeking More Money, Information For Stockholders Of Ardea Biosciences, Inc. - PR Newswire 05.01.12 | 10:05 am
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Ardea Biosciences, Inc. In Connection With The Sale Of The Company To AstraZeneca - PR Newswire 04.24.12 | 05:04 pm
- Law Office Of Brodsky & Smith, LLC Announces Investigation Of Ardea Biosciences, Inc. - PR Newswire 04.24.12 | 12:04 pm
- Ardea Biosciences, Inc. Board Of Directors Under Investigation For Potential Breaches Of Fiduciary Duty By Law Offices Of Howard G. Smith - Business Wire 04.24.12 | 11:04 am
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Ardea Biosciences, Inc. In Connection With The Sale Of The Company To AstraZeneca - Business Wire 04.24.12 | 08:04 am
- Harwood Feffer LLP Announces Investigation Of Ardea Biosciences, Inc. - PR Newswire 04.23.12 | 04:04 pm
- The Law Firm Of Weiss & Lurie Investigates Ardea Biosciences, Inc. - Business Wire 04.23.12 | 03:04 pm
- Law Firm Brower Piven Announces Investigation In Connection With The Acquisition Of Ardea Biosciences, Inc. By AstraZeneca Biopharmaceuticals Inc. - Business Wire 04.23.12 | 12:04 pm
- The Law Firm Of Levi & Korsinsky, LLP Announces Investigation Into Possible Breaches Of Fiduciary Duty By The Board Of Ardea Biosciences, Inc. In Connection With The Sale Of The Company To AstraZeneca - Business Wire 04.23.12 | 11:04 am
- Ardea Biosciences Merger Investigated By The Securities Attorneys At The Briscoe Law Firm And Powers Taylor, LLP - Business Wire 04.23.12 | 11:04 am
Partner Headlines for RDEA
- M&A Weekly Recap: Facebook Buys Face.com, CMH Bidding War - Wall St. Cheat Sheet 06.24.12 | 10:06 am
- Mergers and Acquisitions Recap: BP Considers BG Group BUY, AstraZeneca FINALIZES Ardea Purchase - Wall St. Cheat Sheet 06.20.12 | 04:06 am
- Facebook's SLAUGHTER and 4 Stocks Hitting 52-Week Lows - Wall St. Cheat Sheet 06.06.12 | 11:06 am
- Company News for April 24, 2012 - Corporate Summary - Zacks 04.24.12 | 10:04 am
- Zacks Bull and Bear of the Day Highlights: UnitedHealth Group, Citi Trends, AstraZeneca plc, Ardea Biosciences and Takeda Pharmaceutical - Press Releases - Zacks 04.24.12 | 09:04 am
- Ardea Biosciences Surges 51% After Buyout - Benzinga 04.23.12 | 09:04 am
- Ardea Posts Lower Revs, Wider Loss - Analyst Blog - Zacks 03.12.12 | 10:03 am
- Ardea Agrees with FDA on Gout Candidate - Analyst Blog - Zacks 09.09.11 | 04:09 pm
- Costs Push Up Loss at Ardea - Analyst Blog - Zacks 08.09.11 | 10:08 am
- Zacks #1 Rank Additions for Tuesday - Tale of the Tape - Zacks 07.19.11 | 09:07 am
